Work

Silencing CD24 Inhibits Proliferation, Migration, and Chemoresistance in Triple-Negative Breast Cancer Cells

Year: 2026

Type: article

Source: Pharmaceutical Research

DOI: 10.1007/s11095-026-04046-y

Authors: Yanli Liu, Yuhan Guo, Chien-Yu Lin, Yuanyuan Zhang, Guangfu Li, Kun Cheng

Institutions: University of Missouri–Kansas City, Wake Forest University Health Sciences, Wake Forest University, UConn Health

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: University of Missouri-Kansas City, National Institutes of Health, National Cancer Institute

Awards: Development of a targeted delivery platform for checkpoint inhibitors, Normalizing PDAC stroma with PCBP2 siRNA nanoparticles to improve the antitumor activity of chemotherapy and immunotherapy

OpenAlex ID: W7131235918

FWCI: 3.175

Cites: 51

Cited by: 1

Related to: 10